ATR FINANCIAL STATEMENTS

AptarGroup Inc — balance sheet, income statement and cash flow trends

ATRAptarGroup Inc

🇺🇸 USA · NYSE · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue3.9 B $+8.9%

Gross Profit1.1 B $-13.2%

Operating Income504.4 M $+0.9%

EBITDA834.9 M $+6.8%

Net Income386.7 M $+4.4%

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ATR	8.9%	29.0%	21.6%	10.0%
FPH	4.8%	64.2%	34.9%	20.0%
RMD	10.5%	61.2%	39.1%	27.4%
ANN	11.4%	41.9%	15.2%	6.7%
EL	7.5%	60.6%	23.0%	8.1%
Industry median	6.4%	53.7%	13.8%	3.9%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ATR	8.9%	29.0%	21.6%	10.0%
RGEN	18.2%	50.3%	22.6%	6.7%
AVTR	-2.0%	32.1%	1.9%	-8.4%
TFX	-6.6%	53.3%	-3.1%	-35.9%
BAX	5.1%	30.1%	6.5%	-9.7%
ALGN	2.9%	67.7%	22.2%	10.5%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity2.6 B $52%
Current Liabilities1.1 B $21%
Long-term Liabilities1.4 B $27%

Key Figures

YoY change

Total Assets5.1 B $+12.6%

Total Liabilities2.4 B $+22.7%

Total Equity2.6 B $+3.6%

Cash & ST Investments229.5 M $+67.7%

Total Debt1.4 B $+33.3%

Net Debt1.2 B $+27.4%

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ATR	1.66	53.6%	1.41	51.6%
FPH	2.31	6.9%	-0.39	74.1%
RMD	3.01	13.0%	-0.38	73.9%
ANN	2.36	46.2%	2.10	59.3%
EL	0.99	37.0%	1.66	60.9%
Industry median	2.40	34.8%	1.44	62.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ATR	1.66	53.6%	1.41	51.6%
RGEN	9.20	32.7%	-0.56	71.8%
AVTR	1.76	68.3%	27.87	47.9%
TFX	2.55	87.1%	-26.86	45.5%
BAX	1.85	160.3%	10.39	30.4%
ALGN	1.39	2.8%	-1.04	65.7%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow606 M $-4.4%

Capital Expenditures280.5 M $+0.9%

Free Cash Flow325.5 M $-8.6%

Dividends Paid-121.8 M $-204.2%

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ATR	15.6%	8.4%	7.2%	156.7%
FPH	28.4%	21.0%	7.4%	141.7%
RMD	34.2%	31.7%	2.5%	124.8%
ANN	11.7%	8.3%	3.4%	173.5%
EL	18.6%	13.2%	5.4%	228.6%
Industry median	13.8%	8.6%	3.8%	128.3%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ATR	15.6%	8.4%	7.2%	156.7%
RGEN	17.1%	13.6%	3.5%	254.3%
AVTR	8.7%	6.7%	2.0%	-104.0%
TFX	11.2%	8.9%	3.0%	-31.2%
BAX	11.1%	6.3%	4.7%	-113.9%
ALGN	16.9%	16.8%	4.6%	160.9%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ATR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.